Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm.
Michael J
MJ
Curtis
Michael K
MK
Pugsley
D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000639:trends*; D004345:Drug Industry / Q000639:trends; D006801:Humans